Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Spendlove

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|August 21, 2008
Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survivalIan Spendlove, Ahmad Al-Attar, Oliver Watherstone, et al.
Breast Cancer Research and Treatment|November 27, 2018
Connexin 43 is an independent predictor of patient outcome in breast cancer patientsMaria Chasampalioti, Andrew R Green, Ian O Ellis, et al.
World Journal of Surgical Oncology|July 21, 2005
Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patientsNicholas F S Watson, Zahra Madjd, Duncan Scrimegour, et al.
The British Journal of Nutrition|August 16, 2016
A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammationNeil C Williams, Michael A Johnson, Dominick E Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancerTimothy J Duncan, Phil Rolland, Suha Deen, et al.
The Journal of Pathology|July 19, 2022
The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosaKazuyo Kaneko, Abed M Zaitoun, Darren P Letley, et al.
International Journal of Cancer|July 9, 2005
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosisNicholas F S Watson, Judith M Ramage, Zahra Madjd, et al.
Cancer Immunology, Immunotherapy : CII|September 21, 2004
Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?Zahra Madjd, Lindy G Durrant, Sarah E Pinder, et al.
Cancer Immunity|October 24, 2007
Upregulation of MICA on high-grade invasive operable breast carcinomaZahra Madjd, Ian Spendlove, Robert Moss, et al.
The Journal of Biological Chemistry|December 14, 2019
The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibodyCaroline Soliman, Jia Xin Chua, Mireille Vankemmelbeke, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|August 21, 2008
Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survivalIan Spendlove, Ahmad Al-Attar, Oliver Watherstone, et al.
Breast Cancer Research and Treatment|November 27, 2018
Connexin 43 is an independent predictor of patient outcome in breast cancer patientsMaria Chasampalioti, Andrew R Green, Ian O Ellis, et al.
World Journal of Surgical Oncology|July 21, 2005
Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patientsNicholas F S Watson, Zahra Madjd, Duncan Scrimegour, et al.
The British Journal of Nutrition|August 16, 2016
A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammationNeil C Williams, Michael A Johnson, Dominick E Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancerTimothy J Duncan, Phil Rolland, Suha Deen, et al.
The Journal of Pathology|July 19, 2022
The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosaKazuyo Kaneko, Abed M Zaitoun, Darren P Letley, et al.
International Journal of Cancer|July 9, 2005
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosisNicholas F S Watson, Judith M Ramage, Zahra Madjd, et al.
Cancer Immunology, Immunotherapy : CII|September 21, 2004
Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?Zahra Madjd, Lindy G Durrant, Sarah E Pinder, et al.
Cancer Immunity|October 24, 2007
Upregulation of MICA on high-grade invasive operable breast carcinomaZahra Madjd, Ian Spendlove, Robert Moss, et al.
The Journal of Biological Chemistry|December 14, 2019
The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibodyCaroline Soliman, Jia Xin Chua, Mireille Vankemmelbeke, et al.
Pageof 5